Invention herewith described refers to the treatment with anti-vegf antibodies i.e. to the treatment of diseases and pathological conditions with anti-VEGF antibodies. More particularly, this invention relates to the treatment of human patients who are susceptible to or diagnosed with cancer by using anti-VEGF antibodies, preferably in combination with one or more therapeutic agents against tumors.Ovaj pronalazak se odnosi na tretman bolesti i patoloških stanja sa anti-VEGF antitelima. Određenije, ovaj pronalazak se odnosi na tretman humanih pacijenata koji su podložni ili sa dijagnozom kancera, korišćenjem anti-VEGF antitela, poželjno u kombinaciji sa jednim ili više terapeutskih agenasa protiv tumora.